Closed · W81XWH-10-PRCRP-TNIA · CFDA 12.420 · Discretionary
DOD Peer Reviewed Cancer Translational New Investigator Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- October 20, 2010
- Close date
- 10
- Expected awards
The verdict
DOD Peer Reviewed Cancer Translational New Investigator Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 10 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 10
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DOD Peer Reviewed Cancer Translational New In… is closed (last close October 20, 2010). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed October 20, 2010
Est. Total Funding
$4,500,000
Expected Awards
10
Instrument
Grant
Description
The PRCRP Translational New Investigator Award mechanism is being offered for the first time in FY10. The Translational New Investigator Award supports the development of translational research partnerships among two independent investigators to address at least one of the FY10 PRCRP Topic Areas in a manner relevant to military beneficiaries. Within the partnership, one member must be a laboratory scientist and the other must be a clinician. This award is intended to support a mentoring partnership between a new investigator (the Principal Investigator [PI]) and a mentor (a clinician or laboratory scientist with an established research program in one of the FY10 PRCRP Topic Areas). The ultimate goal of translational research is to move an observation forward into a clinical application. Research does not have to be performed in the clinic but should include human anatomical substances. The Translational New Investigator Award supports preclinical studies in animal models and/or human anatomical substances that have clear potential for translation into clinical applications. Correlative studies that are associated with an existing clinical trial, and/or projects that develop clinical endpoints for clinical trials may be proposed. Developing the research plan must involve a reciprocal flow of ideas and information within the research team (from bench to bedside, and from bedside to bench). Research involving human subject participation is permitted under this funding opportunity but is restricted to studies without clinical trials. Clinical trials are not permitted under this award mechanism. In general, a clinical trial is defined as a prospective study where an intervention (e.g., a device, drug, behavioral, surgical procedure) is tested on human subjects for a measurable outcome. Correlative Human Subject Use (clinical research) studies are permitted, and the study may be associated with a clinical trial, but it does not seek the main outcomes of the clinical trial. Correlative studies are defined as a prospective or retrospective collection of human anatomical substances (tissue, blood, nail clippings, bone marrow, behavioral documentation, etc.) to be used in research to answer a question regarding the disease and /or interventions. Correlative studies do not include the direct testing for the outcome of any intervention for the prevention, diagnosis, treatment, or evaluation of the quality of life of the patient. Correlative Human Subject Use may require informed consent of the human subject, and may include identifiable information. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. For FY10, the PRCRP Translational New Investigator Award will only consider applications that address one or more of the following FY10 PRCRP Topic Areas.
Catch-all / unrestricted eligibility mark · W81XWH-10-PRCRP-TNIA
Grants.gov marks DOD Peer Reviewed Cancer Translational New In… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DOD Peer Reviewed Cancer Translational New In… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |